Literature DB >> 21225138

Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells.

Rubens Camargo Siqueira1, Júlio Cesar Voltarelli, André Marcio Vieira Messias, Rodrigo Jorge.   

Abstract

Bone marrow has been proposed as a potential source of stem cells for regenerative medicine. In the eye, degeneration of neural cells in the retina is a hallmark of such widespread ocular diseases as age-related macular degeneration (AMD) and retinitis pigmentosa. Bone marrow is an ideal tissue for studying stem cells mainly because of its accessibility. Furthermore, there are a number of well-defined mouse models and cell surface markers that allow effective study of hematopoiesis in healthy and injured mice. Because of these characteristics and the experience of bone marrow transplantation in the treatment of hematological disease such as leukemia, bone marrow-derived stem cells have also become a major tool in regenerative medicine. Those cells may be able to restore the retina function through different mechanisms: A) cellular differentiation, B) paracrine effect, and C) retinal pigment epithelium repair. In this review, we described these possible mechanisms of recovery of retinal function with the use of cell therapy with bone marrow-derived stem cells.

Entities:  

Mesh:

Year:  2010        PMID: 21225138     DOI: 10.1590/s0004-27492010000500019

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  19 in total

Review 1.  Stem cell therapy for retinal diseases.

Authors:  José Mauricio Garcia; Luisa Mendonça; Rodrigo Brant; Murilo Abud; Caio Regatieri; Bruno Diniz
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 2.  Stem cell therapy for retinal diseases: update.

Authors:  Rubens Camargo Siqueira
Journal:  Stem Cell Res Ther       Date:  2011-12-29       Impact factor: 6.832

3.  Evaluating role of bone marrow-derived stem cells in dry age-related macular degeneration using multifocal electroretinogram and fundus autofluorescence imaging.

Authors:  Atul Kumar; Neha Midha; Sujata Mohanty; Annu Chohan; Tulika Seth; Varun Gogia; Shikha Gupta
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

Review 4.  Stem cell-based therapies for age-related macular degeneration: current status and prospects.

Authors:  Yalin Mu; Manli Zhao; Guangming Su
Journal:  Int J Clin Exp Med       Date:  2014-11-15

5.  The Chemokine Receptors Ccr5 and Cxcr6 Enhance Migration of Mesenchymal Stem Cells into the Degenerating Retina.

Authors:  Martina Pesaresi; Sergi A Bonilla-Pons; Ruben Sebastian-Perez; Umberto Di Vicino; Marc Alcoverro-Bertran; Ralph Michael; Maria Pia Cosma
Journal:  Mol Ther       Date:  2020-12-01       Impact factor: 11.454

6.  Neural stem/progenitor cells circulating in peripheral blood of patients with neovascular form of AMD: a novel view on pathophysiology.

Authors:  Anna Machalińska; Patrycja Kłos; Krzysztof Safranow; Violetta Dziedziejko; Michał Rudnicki; Edyta Paczkowska; Danuta Karczewicz; Bogusław Machaliński
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-17       Impact factor: 3.117

7.  Translational research in retinology.

Authors:  Rubens Camargo Siqueira; Rodrigo Jorge
Journal:  Clin Ophthalmol       Date:  2011-10-14

8.  Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up.

Authors:  Ensieh Nasli-Esfahani; Maryam Ghodsi; Peyvand Amini; Abbas Ali Keshtkar; Somayeh Amiri; Nika Mojahed-Yazdi; Ali Tootee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2015-04-22

9.  Stem cell therapy in retinal diseases?

Authors:  Rubens Camargo Siqueira
Journal:  Rev Bras Hematol Hemoter       Date:  2012

10.  Choice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A Review.

Authors:  Sudhakar John; Sundaram Natarajan; Periyasamy Parikumar; Mahesh Shanmugam P; Rajappa Senthilkumar; David William Green; Samuel J K Abraham
Journal:  J Ophthalmol       Date:  2013-04-22       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.